000 01314 a2200337 4500
005 20250515171052.0
264 0 _c20090709
008 200907s 0 0 eng d
022 _a0039-6257
024 7 _a10.1016/j.survophthal.2009.02.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTuñón, José
245 0 0 _aCardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
_h[electronic resource]
260 _bSurvey of ophthalmology
_c
300 _a339-48 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAngiogenesis Inhibitors
_xadverse effects
650 0 4 _aCardiovascular Diseases
_xchemically induced
650 0 4 _aChoroidal Neovascularization
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMacular Degeneration
_xdrug therapy
650 0 4 _aRisk Factors
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
700 1 _aRuiz-Moreno, José María
700 1 _aMartín-Ventura, José Luis
700 1 _aBlanco-Colio, Luis M
700 1 _aLorenzo, Oscar
700 1 _aEgido, Jesús
773 0 _tSurvey of ophthalmology
_gvol. 54
_gno. 3
_gp. 339-48
856 4 0 _uhttps://doi.org/10.1016/j.survophthal.2009.02.003
_zAvailable from publisher's website
999 _c18851470
_d18851470